Sato M, Ribas C, Hildebrandt J D, Lanier S M
Department of Pharmacology, Medical University of South Carolina, Charleston, South Carolina 29425, USA.
J Biol Chem. 1996 Nov 22;271(47):30052-60. doi: 10.1074/jbc.271.47.30052.
Purified bovine brain G-protein was used in a solution phase assay to identify membrane-associated proteins that influenced the activation of heterotrimeric G-proteins. Detergent-solubilized membrane extracts from the neuroblastoma-glioma cell hybrid NG108-15, but not the parent C6B4 glioma cell line, increased [35S]GTPgammaS binding to purified G-protein by approximately 460%. The G-protein activator was heat-sensitive, and the magnitude of its action was related to the amount of extract protein. The biophysical and biochemical properties of the G-protein activator were determined using DEAE ion exchange chromatography, gel filtration, and a lectin affinity matrix. In the presence of added GDP (1 microM), the enriched G-protein activator increased the initial rate of [35S]GTPgammaS binding to brain G-protein by up to 4-fold. In the absence of added GDP, the G-protein activator elicited an initial burst in [35S]GTPgammaS binding to brain G-protein within the first 30 s, after which the rate of nucleotide binding to G-protein was similar in the absence or presence of the G-protein activator. The stimulation of nucleotide binding to brain G-protein by the activator was also observed after resolution of Galpha from Gbetagamma. The G-protein activator was distinct from other proteins (neuromodulin, tubulin, and beta-amyloid precursor protein) that influence nucleotide binding to G-protein, indicating the existence of a novel signal accelerator.
纯化的牛脑G蛋白用于溶液相分析,以鉴定影响异源三聚体G蛋白激活的膜相关蛋白。神经母细胞瘤-胶质瘤细胞杂交体NG108-15的去污剂溶解膜提取物(而非亲本C6B4胶质瘤细胞系)可使[35S]GTPγS与纯化G蛋白的结合增加约460%。G蛋白激活剂对热敏感,其作用强度与提取物蛋白量相关。使用DEAE离子交换色谱、凝胶过滤和凝集素亲和基质确定了G蛋白激活剂的生物物理和生化特性。在添加GDP(1μM)的情况下,富集的G蛋白激活剂可使[35S]GTPγS与脑G蛋白结合的初始速率提高多达4倍。在不添加GDP的情况下,G蛋白激活剂在最初30秒内引发[35S]GTPγS与脑G蛋白结合的初始爆发,之后在有无G蛋白激活剂的情况下,核苷酸与G蛋白的结合速率相似。在将Gα与Gβγ分离后,也观察到激活剂对脑G蛋白核苷酸结合的刺激作用。G蛋白激活剂与其他影响核苷酸与G蛋白结合的蛋白(神经调节蛋白、微管蛋白和β淀粉样前体蛋白)不同,表明存在一种新型信号加速器。